Metronidazole treats a remarkably wide range of infections caused by anaerobic bacteria and certain parasites, along with a handful of conditions that are not infections at all. First introduced in the late 1950s for a single parasitic disease, it has since become one of the most prescribed antimicrobials in the world, used in gynecology, gastroenterology, dentistry, surgery, dermatology, and even veterinary medicine. The breadth of its uses reflects one unusual property: metronidazole is selectively toxic to organisms that thrive without oxygen, which means it can reach into biological niches most other antibiotics cannot.
Parasitic Infections
Metronidazole was originally developed to treat trichomoniasis, a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. It remains the standard treatment for that infection decades later, and it is generally effective with a low risk of serious side effects. Research has shown, however, that roughly 5% of trichomoniasis cases involve parasites with some degree of resistance to the drug, and because no approved alternatives exist, those patients often need higher (and sometimes poorly tolerated) doses.1PubMed Central. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis The traditional approach was a single large dose, but a randomized trial found that a seven-day course cleared the infection more reliably in women, with about 11% testing positive afterward compared to 19% with the single dose.2PubMed Central. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial
Giardiasis, the intestinal infection caused by Giardia lamblia and often picked up from contaminated water, also responds well to metronidazole. A five- to seven-day course cures over 90% of cases.3PubMed Central. Treatment of giardiasis The drug is equally useful against amoebiasis, the sometimes dangerous infection caused by Entamoeba histolytica, which can invade the intestinal wall and occasionally spread to the liver. All three of these protozoal diseases were among the earliest established uses for metronidazole and remain core indications today.4Oxford Academic (Clinical Infectious Diseases). Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
Bacterial Vaginosis
Bacterial vaginosis is the most common vaginal condition in women of reproductive age, and it is not caused by a single pathogen but by a shift in the normal vaginal bacterial community. Gardnerella vaginalis and several other anaerobic species overgrow while beneficial lactobacilli decline. Because the culprits are anaerobes, metronidazole is a go-to treatment. It can be taken orally or applied as an intravaginal gel, and the cure rates are similar either way. In one head-to-head trial, about 71% of women in both the oral and vaginal-gel groups were free of bacterial vaginosis at the final follow-up visit.5PubMed. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy A systematic review and meta-analysis of randomized trials confirmed that microbiological cure rates do not differ significantly between the two routes.6Journal of Infection and Chemotherapy. Comparison of oral and intravaginal metronidazole for the treatment of bacterial vaginosis: A systematic review and meta-analysis of randomized controlled trials
The vaginal gel does offer one practical advantage: because blood levels after intravaginal use are only about 2% of what you see after a standard oral dose, the gel produces fewer systemic side effects like nausea or metallic taste.7PubMed. Pharmacokinetics of intravaginal metronidazole gel For women who have had GI trouble on oral metronidazole in the past, the gel route is worth discussing with a provider.
Gastrointestinal Infections and Stomach Ulcers
Metronidazole has a long history in the gut. For decades it was a first-line treatment for Clostridioides difficile infection (often called C. diff), the antibiotic-associated diarrhea that can turn dangerous in hospitalized and elderly patients. In Western guidelines, oral vancomycin and fidaxomicin have now overtaken metronidazole for this role because they perform better in clinical trials. Still, metronidazole continues to be recommended in some regions for non-severe C. diff cases, particularly where the newer drugs are expensive or unavailable.8PubMed. Reappraisal of the clinical role of metronidazole therapy for Clostridioides difficile infection in Taiwan: A multicenter prospective study
Metronidazole also shows up in combination regimens for Helicobacter pylori, the bacterium linked to stomach ulcers and gastric cancer. It is not used alone for this purpose. Instead, it forms one arm of a multi-drug “quadruple therapy” that typically pairs a proton pump inhibitor, bismuth, and one or two antibiotics. Metronidazole fills one of those antibiotic slots when the patient’s H. pylori strain is sensitive to it.9PubMed. Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori-Infected Peptic Ulcer Children in Vietnam Because H. pylori resistance to metronidazole is common in many parts of the world, susceptibility testing or local resistance data often guides whether it gets included.
Surgical Infection Prevention
Before colorectal surgery, metronidazole is widely used as prophylaxis to prevent wound infections. The colon harbors enormous numbers of anaerobic bacteria, and cutting into it risks contaminating the surgical site. Metronidazole targets those anaerobes effectively, but because aerobic bacteria are also present, it is paired with another antibiotic that covers them. A common combination is a cephalosporin plus metronidazole, given as a single dose or a short course just before and after the procedure.10PubMed. Cost-effectiveness of single dose cefotaxime plus metronidazole compared with three doses each of cefuroxime plus metronidazole for the prevention of wound infection after colorectal surgery This use extends beyond colorectal cases to appendectomies and other abdominal surgeries where anaerobic contamination is a risk.
Dental and Oral Infections
Several painful mouth conditions are driven by anaerobic bacteria that flourish in gum pockets and dental plaque. Acute necrotizing ulcerative gingivitis, sometimes called “trench mouth,” is one of the most dramatic. It causes sudden, severe gum pain, bleeding, and tissue death, and is caused primarily by spirochetes and Fusobacterium species. A week of metronidazole typically brings rapid relief, and studies have shown the bacterial populations responsible stay suppressed for two to three months after treatment ends.11PubMed. The bacteriology of acute necrotizing ulcerative gingivitis Dentists also prescribe it for certain periodontal abscesses and as an adjunct to scaling and root planing in chronic periodontitis, again because the bacteria in deep gum pockets tend to be anaerobic.
Skin Conditions, Especially Rosacea
In an interesting twist, metronidazole has an established role in treating something that isn’t an infection at all. Topical metronidazole cream or gel is a standard treatment for rosacea, the chronic skin condition that causes facial redness, bumps, and pustules. The exact reason it works here is not fully understood. Researchers suspect it may have anti-inflammatory and antioxidant properties separate from its antimicrobial activity. In clinical trials, both 0.75% and 1.0% metronidazole cream reduced inflammatory lesions by roughly 60% and cut redness scores by about a quarter to a third.12PubMed. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea Both strengths were well tolerated. This is a purely topical use with minimal systemic absorption, so the side-effect profile is very different from oral metronidazole.
Brain and Central Nervous System Infections
One of metronidazole’s less widely known strengths is its ability to cross the blood-brain barrier. Many antibiotics cannot penetrate this barrier effectively, which makes treating brain abscesses and meningitis caused by anaerobic bacteria extremely difficult. Metronidazole achieves a cerebrospinal-fluid-to-blood ratio close to 1.0, meaning drug levels in the brain fluid nearly match those in the bloodstream.13PubMed Central. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections That makes it one of a small group of anti-infectives considered extremely valuable for central nervous system infections. Brain abscesses often harbor mixed anaerobic flora, and metronidazole’s penetration gives it a clear advantage in those situations.
Crohn’s Disease Fistulas
Crohn’s disease can produce fistulas, which are abnormal tunnels that form between the intestine and other structures like the skin near the anus. These are painful and notoriously difficult to manage. Metronidazole has been used to help close or reduce fistula drainage in Crohn’s patients. In one early study, the number of draining fistulas dropped dramatically, all patients experienced pain relief, and half achieved complete resolution of symptoms.14PubMed. Metronidazole therapy for Crohn’s disease and associated fistulae
The picture is complicated, though. A small randomized trial comparing metronidazole, ciprofloxacin, and placebo for perianal fistulas showed disappointing results for metronidazole specifically: no patients in the metronidazole group achieved remission by week 10, and five of seven patients dropped out before the study ended, often due to side effects.15PubMed. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled pilot study Ciprofloxacin performed better in that trial. In practice, gastroenterologists sometimes use both antibiotics together, or use metronidazole as a bridge while starting immunosuppressive therapy. It remains part of the toolbox, but expectations about fistula response should be tempered.
The Alcohol Question
If you have ever been prescribed metronidazole, you were almost certainly told to avoid alcohol completely while taking it. The warning is based on a decades-old belief that metronidazole causes a “disulfiram-like reaction” when combined with alcohol: flushing, nausea, vomiting, rapid heart rate. This idea is so firmly embedded in medical culture that it appears on virtually every pharmacy handout. But the evidence behind it has been questioned repeatedly in recent years.
A systematic literature review published in 2025, covering studies from 1970 to 2024, identified eleven studies that met inclusion criteria. While the older case reports and one early clinical trial suggested a possible link, three clinical trials, a chart review, and two animal studies did not find one.16PubMed. Revisiting the Disulfiram-Like Reaction Between Alcohol and Oral Metronidazole A case-control study matched by age, sex, and blood alcohol concentration found results consistent with other well-controlled data showing no increase in acetaldehyde levels or disulfiram-like symptoms when metronidazole and ethanol are taken together.17PubMed. Can Metronidazole Cause a Disulfiram-Like Reaction? A Case-Control Study Propensity Matched by Age, Sex, and Ethanol Concentration Another review characterized the frequency of the reaction as “uncertain” and its severity as “varied.”18PubMed Central. Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions
None of this means it is a great idea to drink heavily during an infection. Alcohol can interfere with recovery and sleep regardless of what antibiotic you are taking. But the strict prohibition printed on metronidazole packaging appears to rest on weaker evidence than most clinicians realize, and the research community has increasingly called it into question.
Side Effects and Neuropathy Risk
For most people on a standard course, the most common complaints are nausea, a metallic taste in the mouth, and headache. These are annoying but not dangerous and generally go away when the drug is stopped. Metronidazole is considered safe and well-tolerated overall, which is one reason it has stayed in such wide use for over six decades.
The more serious concern is neurotoxicity. In rare cases, metronidazole can cause peripheral neuropathy, which means tingling, numbness, or pain in the hands and feet, and very rarely a brain condition called metronidazole-induced encephalopathy.19PubMed Central. Peripheral Neuropathy Induced by a Short Course of Metronidazole: A Case Report of Diagnostic Challenge A systematic review found that this neuropathy is a recognized complication but emphasized that it remains uncommon.20PubMed. Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature The risk goes up with prolonged use and high cumulative doses. If you notice any new tingling or numbness while taking the drug, flag it with your provider immediately; catching it early usually means the symptoms reverse after stopping treatment.
Safety During Pregnancy
Because trichomoniasis and bacterial vaginosis are common during pregnancy, the question of whether metronidazole is safe for a developing fetus comes up frequently. A meta-analysis concluded that metronidazole does not appear to be associated with an increased risk of birth defects.21PubMed. Safety of metronidazole in pregnancy: a meta-analysis A later cohort study from a New York hospital found no association between metronidazole treatment during any trimester and preterm birth, low birth weight, or congenital anomalies.22PubMed Central. Investigation of metronidazole use during pregnancy and adverse birth outcomes Current guidelines in the U.S. permit its use in pregnant women when the infection warrants treatment, though providers generally prefer to avoid it during the first trimester if the condition can safely wait.
Resistance Concerns
No antibiotic stays effective forever, and metronidazole is no exception. Among anaerobic bacteria, resistance has been linked to a family of genes called nim genes, which produce enzymes that inactivate the drug before it can do its job. These genes can sit on mobile genetic elements, meaning they can spread between bacterial species.23PubMed. Metronidazole resistance and nim genes in anaerobes: A review A survey of over 1,500 clinical Bacteroides fragilis group strains from 19 European countries found nim genes in about 2% of isolates. That may sound low, but researchers showed that high-level metronidazole resistance could be induced in those strains under the right conditions, which raises a flag for clinical settings where metronidazole is used heavily.24PubMed Central. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates
The resistance situation varies by organism. Resistance in Trichomonas vaginalis hovers around 5%, as mentioned earlier. Resistance in H. pylori is much higher in many parts of the world, which is why susceptibility testing matters before including metronidazole in an eradication regimen. Among the anaerobic bacteria metronidazole was designed to target, resistance is still uncommon enough that the drug remains a workhorse, but the trend deserves monitoring.
Veterinary Uses
If you have a dog or cat, you may have encountered metronidazole prescribed by a veterinarian. It is one of the most commonly dispensed antibiotics in small-animal practice. A survey of veterinary prescriptions found that metronidazole was most frequently given for acute diarrhea (about 47% of prescriptions), followed by chronic diarrhea and giardiasis.25PubMed Central. Understanding the rationale for metronidazole use in dogs and cats In a randomized, placebo-controlled trial in dogs with acute diarrhea, those treated with metronidazole recovered in an average of about two days versus nearly four days for the placebo group, and the drug significantly reduced carriage of Clostridium perfringens.26PubMed Central. Metronidazole treatment of acute diarrhea in dogs: A randomized double blinded placebo‐controlled clinical trial
Veterinary use mirrors human medicine in many ways, but one difference stands out: there is ongoing debate in the veterinary world about whether metronidazole is overprescribed for self-limiting diarrhea in pets, especially given its potential for neurotoxicity at higher doses in dogs. The side effects are the same species to species: nausea, wobbliness at high doses, and in rare cases nerve damage. Pets cannot tell you about tingling in their paws, so the threshold for suspecting neurotoxicity has to be lower.
Why One Drug Covers So Many Conditions
The reason a single drug shows up across parasitology, surgery, gastroenterology, gynecology, dentistry, and dermatology traces back to its mechanism. Metronidazole is a prodrug that does nothing until it enters a cell with very low oxygen levels. Inside an anaerobic organism, special electron-transport proteins reduce the drug’s nitro group, generating toxic intermediates that damage DNA and other critical molecules. This activation step happens only in cells that use anaerobic metabolic pathways, which is why the drug spares human cells and aerobic bacteria while hitting anaerobes and certain parasites hard.27PubMed Central. Why metronidazole is active against both bacteria and parasites That selective toxicity is why metronidazole was found to be broadly active against obligate anaerobic bacteria including Bacteroides fragilis and Clostridium difficile after its initial introduction for a single parasitic infection in the 1950s. It is a rare example of a drug whose usefulness kept expanding because the underlying biology connected conditions that look very different on the surface.